Bayat Mokhtari, Reza <br/><br/>
Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma.  [electronic resource] 

 -  BMC cancer  02 2017 
 - 156 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/s12885-017-3126-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetazolamide--pharmacology<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Benzamides--pharmacology<br/>Carbonic Anhydrase Inhibitors--pharmacology<br/>Cell Line<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Drug Therapy, Combination<br/>Female<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Humans<br/>Mice<br/>Neuroblastoma--drug therapy<br/>Pyridines--pharmacology<br/>Treatment Outcome<br/>Xenograft Model Antitumor Assays